ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OXM vs TMO // EV/EBITDA & P/E VALUATION

Oxford Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: OXM 2 — TMO 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OXM VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OXM TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 60.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -4.00% 9.30% -13.30 TMO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield 2.64% 2.40% +0.24 OXM /fcf-yield <GO>
Operating Margin -2.10% 17.40% -19.50 TMO /operating-margins <GO>
Net Profit Margin -1.90% 15.10% -17.00 TMO /net-margins <GO>
Revenue Growth (YoY) -2.60% 3.90% -6.50 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 9.82% 0.24% +9.58 OXM /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.5 62.9 -9.43 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $428.8M $262.22B -$261.79B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OXM REV TMO REV OXM GROSS % TMO GROSS % OXM FCF TMO FCF
FY 2025 $1.48B $44.56B 60.7% — $11.3M $6.29B
FY 2024 $1.52B $42.88B 62.9% — $59.8M $7.27B
FY 2023 $1.57B $42.86B — — $244.3M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OXM // BETA —
TMO // BETA 0.94